All recall categories

Prescription and over-the-counter medication recalls

Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.

4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.

Drugs

Reported Oct 22, 2014

Dipyridamole API, NET WT 10 Kg, Rx Only, S.I.M.S. , Chemical Product for Medicines Preparation, Made in Italy, NDC…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Gyma Laboratories Of Amer,Inc.

3 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Hospira Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02),…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Sagent Pharmaceuticals Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

Atorvastatin Calcium 40 MG Tablet, MFG: Apotex NDC# 6050525808

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Unit Dose Solutions Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Valeant Pharmaceuticals International

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Valeant Pharmaceuticals North America LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 22, 2014

TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Zydus Pharmaceuticals USA Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc.…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Astellas Pharma US Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx Only, Manufactured in USA for…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Bracco Diagnostic Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only,…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Gilead Sciences, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Janssen Ortho LLC

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for Mylan…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Mckesson

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by Mylan Pharmaceuticals, Inc.…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Mylan Pharmaceuticals Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Unique Pharmaceutical, Ltd.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. Manufactured by…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

VistaPharm, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 15, 2014

ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Zydus Pharmaceuticals USA Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by:…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

AbbVie Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by:…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Actavis Laboratories, FL, Inc.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc.,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Cubist Pharmaceuticals, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Eugene Oregon, Inc.

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Hospira Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

All sterile drugs compounded between 2/21/14 and 2/24/14.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

New England Home Therapies, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 8, 2014

Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag packaged in a foil overwrap, Rx only,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Sagent Pharmaceuticals Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 1, 2014

Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only,…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Akorn, Inc.

FDA (openFDA drug enforcement)

Free recall alerts

Get alerted about new Medication recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Related categories

RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.